Wilms tumor: Kidney cancer in children
While kidney cancer is rare in children, Wilms tumor is the most common type found in kids, with between 500 and 600 children diagnosed annually in the U.S. The disease most often affects kids ages 3 to 4. Thanks to advances in treatments over the past several decades, survival rates from this rare cancer have improved significantly. Developing a treatment plan customized for each child with Wilms tumor has also helped to improve the prognosis for children… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - March 24, 2024 Category: Databases & Libraries Source Type: news

How to Manage Anxiety and Depression When You Have Kidney Cancer
When Katie Coleman was diagnosed at age 29 with a softball-sized tumor on her right kidney and a host of smaller growths in her liver, she was stunned. That astonishment quickly gave way to feelings of hopelessness. “I felt like my entire world was being pulled out from under me,” Coleman, now 32, says. “I went into a very dark spiral.” Though her surgeon removed all the tumors, it wasn’t clear what her long- or even short- term prognosis was. What she found on the internet just freaked her out more. “One night I spiraled so deep I didn’t know whether life was worth living anymo...
Source: TIME: Health - March 22, 2024 Category: Consumer Health News Authors: Linda Carroll Tags: Uncategorized freelance healthscienceclimate Source Type: news

'I'm a doctor - these are the three most common red flag symptoms of hidden kidney cancer'
Kidney cancer claims around 13,300 new victims in the UK every year, that's 36 newly diagnosed patients every day. (Source: Daily Express - Health)
Source: Daily Express - Health - March 22, 2024 Category: Consumer Health News Source Type: news

Understanding kidney cancer
March is National Kidney Month, which makes this a good time to learn about kidney cancer. Kidney cancer is cancer that begins in the kidneys, which are two bean-shaped organs, each about the size of your fist. They're behind your abdominal organs, with one kidney on each side of your spine. The kidneys remove waste from your blood and regulate a healthy balance between water, sodium and minerals in your bloodstream. Approximately 81,600 new cases… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - March 16, 2024 Category: Databases & Libraries Source Type: news

A Blood Test for Colon Cancer Shows Promise
A blood test for colon cancer performed well in a study published Wednesday, offering a new kind of screening for a leading cause of cancer deaths. The test looks for DNA fragments shed by tumor cells and precancerous growths. It’s already for sale in the U.S. for $895, but has not been approved by the Food and Drug Administration and most insurers do not cover it. The maker of the test, Guardant Health, anticipates an FDA decision this year. [time-brightcove not-tgx=”true”] In the study, the test caught 83% of the cancers but very few of the precancerous growths found by colonoscopy, the gold stan...
Source: TIME: Health - March 14, 2024 Category: Consumer Health News Authors: Carla K. Johnson/AP Tags: Uncategorized healthscienceclimate wire Source Type: news

Adjuvant IO: Survival Advantage'Big News' in Renal Cancer Adjuvant IO: Survival Advantage'Big News' in Renal Cancer
A 40% reduced risk for death from renal cancer, as reported by KEYNOTE-564, tops Dr Brian Rini ' s list of takeaways from ASCO GU 2024. Also discussed are updates on doublet therapy in advanced disease.Medscape (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 12, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news

After SABR, 100% Local Control at 1 Year in Kidney Cancer After SABR, 100% Local Control at 1 Year in Kidney Cancer
Among patients with primary RCC who did not undergo surgery, SABR led to no local treatment failures at 1 year, new phase 2 data showed.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 12, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news

'I'm super fit and thought I was indestructible - then I was told I had kidney cancer'
Personal trainer Pete Webster wasn't too worried when he spotted blood in his urine, but his wife insisted he saw his GP - potentially saving his life. (Source: Daily Express - Health)
Source: Daily Express - Health - March 11, 2024 Category: Consumer Health News Source Type: news

Q & A: Immunotherapy in Renal Cell Carcinoma (RCC) Q & A: Immunotherapy in Renal Cell Carcinoma (RCC)
A collaboration and conversation between Medscape and Dr Karl D ' Silva on the impact of immunotherapy in renal cell carcinoma.Medscape (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 8, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news

Advancing Equity: Tailored Treatments for Renal Cell Carcinoma Advancing Equity: Tailored Treatments for Renal Cell Carcinoma
Dr Jose A. Karam addresses health disparities in RCC.Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 5, 2024 Category: Consumer Health News Tags: None MDAngle Source Type: news

Navigating Cancer Care in RCC: Reflections and Advancements Navigating Cancer Care in RCC: Reflections and Advancements
Dr Jose A. Karam reflects on navigating dual kidney tumors in his early career, highlighting advancements in kidney cancer care from genetic counseling to immunotherapy.Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 5, 2024 Category: Consumer Health News Tags: None MDAngle Source Type: news

Reflections on Mentorship in Kidney Cancer Care Reflections on Mentorship in Kidney Cancer Care
Dr Jose A. Karam reflects on the transformative mentorship of Dr Christopher Wood.Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 5, 2024 Category: Consumer Health News Tags: None MDAngle Source Type: news

Renal Cell Carcinoma Highlights From ASCO GU 2024 Renal Cell Carcinoma Highlights From ASCO GU 2024
Key data in renal cell carcinoma from ASCO GU 2024 includes pembrolizumab in early higher-risk RCC, belzutifan in advanced disease, and developments in quality-of-life tools.Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 16, 2024 Category: Consumer Health News Tags: Hematology-Oncology ReCAP Source Type: news

Advancements in RCC Treatment and Cure Rates Advancements in RCC Treatment and Cure Rates
Dr Katy Beckermann expresses optimism for the future of the treatment of renal cell carcinoma through the safe combination of new therapeutic agents.Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 16, 2024 Category: Consumer Health News Tags: None MDAngle Source Type: news

Miracle drug that stops killer kidney cancer from coming back to be offered to 80 per cent of NHS patients with the disease
The injection, pembrolizumab, looks set to become the standard treatment given to patients after surgery after a trial saw survival rates soar. (Source: the Mail online | Health)
Source: the Mail online | Health - February 4, 2024 Category: Consumer Health News Source Type: news